NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 343 filers reported holding NATERA INC in Q2 2021. The put-call ratio across all filers is 0.43 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $36,026,138 | -47.5% | 814,150 | -42.3% | 0.07% | -45.5% |
| Q2 2023 | $68,664,466 | -6.9% | 1,411,107 | +6.3% | 0.13% | -14.6% |
| Q1 2023 | $73,716,958 | +23.0% | 1,327,755 | -11.0% | 0.16% | +16.3% |
| Q4 2022 | $59,938,660 | +11.3% | 1,492,125 | +21.4% | 0.14% | +14.4% |
| Q3 2022 | $53,862,000 | +20.8% | 1,229,185 | -2.3% | 0.12% | +28.3% |
| Q2 2022 | $44,577,000 | -22.4% | 1,257,826 | -10.9% | 0.09% | -15.6% |
| Q1 2022 | $57,420,000 | -66.1% | 1,411,506 | -22.3% | 0.11% | -65.2% |
| Q4 2021 | $169,589,000 | +11.9% | 1,815,919 | +33.5% | 0.31% | -50.2% |
| Q3 2021 | $151,530,000 | +5.2% | 1,359,761 | +7.2% | 0.63% | -3.4% |
| Q2 2021 | $143,973,000 | +20.8% | 1,268,144 | +8.0% | 0.65% | +19.0% |
| Q1 2021 | $119,209,000 | +31.4% | 1,174,013 | +28.8% | 0.55% | +11.4% |
| Q4 2020 | $90,689,000 | +6754.8% | 911,254 | +1957.8% | 0.49% | +3676.9% |
| Q1 2020 | $1,323,000 | +150.6% | 44,283 | +73.1% | 0.01% | +550.0% |
| Q1 2019 | $528,000 | – | 25,580 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
| Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
| Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
| Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
| Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
| BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
| Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
| Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
| SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |